Southwest Airlines reports first-quarter earnings, beats revenue estimates

Southwest Airlines reports first-quarter earnings, beats revenue estimates

CNBC’s Phil LeBeau joins ‘Squawk Box’ to break down Southwest Airlines’ first-quarter earnings report.

Read More »
Meta's stock has been too penalized, says LightShed Partners' Rich Greenfield

Meta’s stock has been too penalized, says LightShed Partners’ Rich Greenfield

Rich Greenfield, LightShed Partners co-founder, joins CNBC’s ‘Squawk Box’ to break down the latest earnings report from Facebook’s parent company Meta.

Read More »
Caterpillar reports Q1 earnings, beats revenue and EPS estimates

Caterpillar reports Q1 earnings, beats revenue and EPS estimates

CNBC’s ‘Squawk Box’ team breaks down shares of Caterpillar following the company’s first-quarter earnings report.

Read More »
Archegos founder Bill Hwang, CFO charged in stock market fraud

Archegos founder Bill Hwang, CFO charged in stock market fraud

Archegos founder Bill Hwang is free on bail after being formally charged over accusations of a massive stock market fraud.

Read More »
Merck Q1 earnings beat Wall Street's estimates, raises full-year guidance

Merck Q1 earnings beat Wall Street’s estimates, raises full-year guidance

CNBC’s Meg Tirrell joins ‘Squawk Box’ to break down the latest first-quarter earnings report from drugmaker Merck, which beat Wall Street’s estimates on the top and bottom lines.

Read More »
We still like some Big Tech stocks, depends on investment horizon, says Nancy Tengler

We still like some Big Tech stocks, depends on investment horizon, says Nancy Tengler

Nancy Tengler, CEO and CIO at Laffer Tengler Investments, and Gunjan Banerji, markets reporter at the Wall Street Journal, join CNBC’s ‘Squawk Box’ to discuss tech stocks amid a busy week of earnings.

Read More »
Eli Lilly drug tirzepatide meets weight-loss goals in obesity trial

Eli Lilly drug tirzepatide meets weight-loss goals in obesity trial

A highly anticipated clinical trial from Eli Lilly showed its Type 2 diabetes drug met its primary endpoints. CNBC’s Meg Tirrell joins ‘Squawk Box’ to break down the results.

Read More »
We're at peak inflation and 'peak fear,' says Leuthold Group's Jim Paulsen

We’re at peak inflation and ‘peak fear,’ says Leuthold Group’s Jim Paulsen

Jim Paulsen, chief investment strategist for the Leuthold Group, joins CNBC’s ‘Squawk Box’ to discuss markets ahead of the open on Wednesday.

Read More »